NYMXF (Nymox Pharmaceutical) OCF Margin %: 0.00% (As of Dec. 2024)


What is Nymox Pharmaceutical OCF Margin %?

Nymox Pharmaceutical NYMXF +9.09% OCF Margin % is 0.00% as of Dec. 2024.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Nymox Pharmaceutical's Cash Flow from Operations for the three months ended in Dec. 2024 was $-0.72 Mil. Nymox Pharmaceutical's Revenue for the three months ended in Dec. 2024 was $0.00 Mil. Therefore, Nymox Pharmaceutical's OCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, Nymox Pharmaceutical's current OCF Yield % is -6.32%.

The historical rank and industry rank for Nymox Pharmaceutical's OCF Margin % or its related term are showing as below:


During the past 13 years, the highest OCF Margin % of Nymox Pharmaceutical was -135.88%. The lowest was -200740.00%. And the median was -2689.79%.

NYMXF's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

Nymox Pharmaceutical OCF Margin % Related Terms

Nymox Pharmaceutical OCF Margin % Historical Data

* Premium members only.

The historical data trend for Nymox Pharmaceutical's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nymox Pharmaceutical OCF Margin % Chart

Nymox Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -200,740.00 0.00 0.00 0.00 0.00

Nymox Pharmaceutical Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Sep24 Dec24
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 17,940.00 0.00 0.00

Nymox Pharmaceutical OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Nymox Pharmaceutical's OCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-2.601/0
= %

Nymox Pharmaceutical's OCF Margin for the quarter that ended in Dec. 2024 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-0.717/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Nymox Pharmaceutical (NYMXF) has a OCF Margin % of 0.00% as of Dec. 2024. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nymox Pharmaceutical and its competitors.
Is Nymox Pharmaceutical's OCF Margin % too high?
Nymox Pharmaceutical's current OCF Margin % is 0.00%.
How does Nymox Pharmaceutical's OCF Margin % compare to LYRA and RNAZ?
Nymox Pharmaceutical's OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nymox Pharmaceutical and its competitors. Nymox Pharmaceutical's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nymox Pharmaceutical stock overvalued right now?
Nymox Pharmaceutical (NYMXF) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Nymox Pharmaceutical (NYMXF), the current OCF Margin % is 0.00% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nymox Pharmaceutical Business Description

Address Bay & Deveaux Streets, Nassau, BHS
Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and low-grade localized prostate cancer. The company also has an extensive patent portfolio covering its investigational drug as well as other therapeutic and diagnostic indications. It also has U.S. and patent rights for the use of statin drugs for the treatment and prevention of Alzheimer's disease. The company operates in one reportable segment, focused on researching and developing products for the aging population.